Details for New Drug Application (NDA): 062029
✉ Email this page to a colleague
NDA 062029 describes PENICILLIN G PROCAINE, which is a drug marketed by Consolidated Pharm, King Pharms Llc, Parke Davis, and Pfizer, and is included in four NDAs. Additional details are available on the PENICILLIN G PROCAINE profile page.
The generic ingredient in PENICILLIN G PROCAINE is penicillin g procaine. There are ninety-two drug master file entries for this compound. Additional details are available on the penicillin g procaine profile page.
The generic ingredient in PENICILLIN G PROCAINE is penicillin g procaine. There are ninety-two drug master file entries for this compound. Additional details are available on the penicillin g procaine profile page.
Summary for 062029
| Tradename: | PENICILLIN G PROCAINE |
| Applicant: | Parke Davis |
| Ingredient: | penicillin g procaine |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 062029
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 300,000 UNITS/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
